TheStreet

Log In

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?Don't have an account? Sign Up Here

Join Us

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Already have an account? Login here
TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTCRYPTOMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTERTECHNOLOGY
Search

Trade with Jim Cramer 14 Days Free

Join the Action Alerts PLUS Community today!

SUBSCRIBE NOW

LATEST NEWS

Perilous Reversal Watch: Golar LNG (GLNG)
MARKETS

3 Stocks Boosting The Health Care Sector Higher

  • By TheStreet Wire
  • Aug 21, 2015 4:34 PM EDT
PRESS RELEASES

Cellectar To Present At BIO CEO & Investor Digital Conference

  • By GlobeNewswire
  • Feb 10, 2021 8:30 AM EST
PRESS RELEASES

Cellectar Receives Orphan Drug Designation From The European Commission For CLR 131 In Waldenstrom's Macroglobulinemia

  • By GlobeNewswire
  • Jan 27, 2021 8:30 AM EST
PRESS RELEASES

Cellectar Initiates Pivotal Trial Of CLR 131 In Waldenstrom's Macroglobulinemia

  • By GlobeNewswire
  • Jan 12, 2021 8:30 AM EST
PRESS RELEASES

Cellectar Biosciences Announces Closing Of $24.5 Million Underwritten Public Offering And $20.5 Million Concurrent Private Placement

  • By GlobeNewswire
  • Dec 28, 2020 4:05 PM EST
PRESS RELEASES

Cellectar Biosciences Announces Pricing Of $24.5 Million Underwritten Public Offering And $20.5 Million Concurrent Private Placement

  • By GlobeNewswire
  • Dec 23, 2020 8:38 AM EST
PRESS RELEASES

Cellectar Biosciences Announces Proposed Underwritten Public Offering And Concurrent Private Placement

  • By GlobeNewswire
  • Dec 22, 2020 5:27 PM EST
PRESS RELEASES

Cellectar Biosciences' CLR 131 Demonstrates Preliminary Activity In Phase I Study For Pediatric Brain And Solid Tumors

  • By GlobeNewswire
  • Nov 5, 2020 9:00 AM EST
PRESS RELEASES

Cellectar Reports Data On CLR 131 Phase 2 CLOVER-1 Study In Triple Class Refractory Multiple Myeloma Patients

  • By GlobeNewswire
  • Sep 9, 2020 8:00 AM EDT
PRESS RELEASES

Cellectar Presents Poster At The AACR VIRTUAL MEETING: ADVANCES IN MALIGNANT LYMPHOMA

  • By GlobeNewswire
  • Aug 17, 2020 10:01 AM EDT
PRESS RELEASES

Cellectar Announces Poster Presentation At The International Symposium On Pediatric Neuro-Oncology (ISPNO) Annual Meeting

  • By GlobeNewswire
  • Aug 4, 2020 8:00 AM EDT
PRESS RELEASES

Cellectar Appoints Dr. John Friend As Chief Medical Officer

  • By GlobeNewswire
  • Jul 1, 2020 8:00 AM EDT
PRESS RELEASES

Cellectar To Be Granted EU Patent For Phospholipid Ether (PLE) Analogs As Cancer-Targeting Drug Vehicles

  • By GlobeNewswire
  • Jun 11, 2020 8:30 AM EDT
PRESS RELEASES

Cellectar Biosciences Announces Closing Of $20 Million Underwritten Public Offering

  • By GlobeNewswire
  • Jun 5, 2020 4:01 PM EDT
PRESS RELEASES

Cellectar Biosciences Announces Pricing Of $20 Million Underwritten Public Offering

  • By GlobeNewswire
  • Jun 3, 2020 9:00 AM EDT
PRESS RELEASES

Cellectar Receives FDA Fast Track Designation For CLR 131 In Lymphoplasmacytic Lymphoma/Waldenstrom's Macroglobulinemia

  • By GlobeNewswire
  • May 26, 2020 7:45 AM EDT
PRESS RELEASES

Cellectar Granted Composition Of Matter And Use Patent In Europe For CLR 131

  • By GlobeNewswire
  • May 14, 2020 8:00 AM EDT
Perilous Reversal Watch: Golar LNG (GLNG)
MARKETS

3 Stocks Boosting The Health Care Sector Higher

  • By TheStreet Wire
  • Aug 21, 2015 4:34 PM EDT
3 Leisure Stocks Pushing Industry Growth
MARKETS

3 Stocks Driving The Drugs Industry Higher

  • By TheStreet Wire
  • Aug 21, 2015 4:33 PM EDT
Barbarian At The Gate: Annaly Capital Management (NLY)
MARKETS

3 Stocks Pushing The Drugs Industry Lower

  • By TheStreet Wire
  • Aug 11, 2015 4:34 PM EDT
Insider Trading Alert - DUK, STFC And RGLS Traded By Insiders
MARKETS

3 Stocks Driving The Drugs Industry Higher

  • By TheStreet Wire
  • Jul 30, 2015 4:33 PM EDT
Insider Trading Alert - RYL, BHB And AAL Traded By Insiders
MARKETS

3 Stocks Pushing The Drugs Industry Lower

  • By TheStreet Wire
  • Mar 9, 2015 4:34 PM EDT
Today's Weak On High Volume Stock: Ocean Rig UDW (ORIG)
MARKETS

3 Stocks Pushing The Drugs Industry Lower

  • By TheStreet Wire
  • Mar 5, 2015 3:35 PM EST
Jones Lang LaSalle (JLL) Reaches New Lifetime High Today
MARKETS

3 Stocks Pushing The Drugs Industry Lower

  • By TheStreet Wire
  • Feb 9, 2015 4:32 PM EST
3 Basic Materials Stocks Driving The Sector Higher
MARKETS

3 Stocks Pushing The Drugs Industry Lower

  • By TheStreet Wire
  • Jan 30, 2015 4:32 PM EST
TheStreet
  • Terms Of Use
  • Privacy Policy
  • Advertise
  • Reprints
  • Customer Service
  • Data
  • Topic Archive
  • Subscriptions
© 2021 TheStreet, Inc. All rights reserved. Action Alerts PLUS is a registered trademark of TheStreet, Inc.